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ABSTRACT: The eﬃcient engineering of iminium biocatalysis
has drawn considerable attention, with many applications in
pharmaceutical synthesis. Here, we report a tailor-made iminium-
activated colorimetric “turn-on” probe, speciﬁcally designed as a
prescreening tool to facilitate engineering of iminium biocatalysis.
Upon complexation of the probe with the catalytic Pro-1 residue of
the model enzyme 4-oxalocrotonate tautomerase (4-OT), a
brightly colored merocyanine-dye-type structure is formed. 4-OT
mutants that formed this brightly colored species upon incubation
with the probe proved to have a substantial activity for the
iminium-based Michael-type addition of nitromethane to cinna-
maldehyde, whereas mutants that showed no staining by the probe
exhibited no or very low-level “Michaelase” activity. This system was exploited in a solid-phase prescreening assay termed as
activated iminium colony staining (AICS) to enrich libraries for active mutants. AICS prescreening reduced the screening eﬀort up
to 20-fold. After two rounds of directed evolution, two artiﬁcial Michaelases were identiﬁed with up to 39-fold improvement in the
activity for the addition of nitromethane to cinnamaldehyde, yielding the target γ-nitroaldehyde product with excellent isolated yield
(up to 95%) and enantiopurity (up to >99% ee). The colorimetric activation of the turn-on probe could be extended to the class I
aldolase 2-deoxy-D-ribose 5-phosphate aldolase, implicating a broader application of AICS in engineering iminium biocatalysis.
■ INTRODUCTION
Iminium-based catalysts are among the most versatile catalysts,
ﬁnding applications in a myriad of C−C bond-forming
transformations.1 Many of these transformations lead to the
formation of one or more asymmetric carbon atoms. Hence,
researchers have focused on the discovery and engineering of
iminium-based enzymes that could be applied as biocata-
lysts.2−4 Unfortunately, nature’s repertoire of iminium-based
carboligases is limited. This has motivated researchers to
supplement natural iminium-based biocatalysts with artiﬁcial
biocatalysts, either obtained by computational design5,6 or
inspired by natural scaﬀolds.7,8 Regardless of the source of the
biocatalyst, enzyme engineering is often required to improve
the catalytic rate, enantioselectivity, or stability. In the Hilvert
laboratory, the computationally designed retroaldolase RA95.0
was engineered toward Michael-type additions,9 aldol reac-
tions,10,11 Knoevenagel condensations,12 and Henry condensa-
tions.13 In our group, we have focused on the engineering of a
natural tautomerase, 4-oxalocrotonate tautomerase (4-OT). By
exploiting the nucleophilic character of the key catalytic
residue Pro-1, we have engineered 4-OT towards several
enamine or iminium-mediated C−C bond-forming reactions,
including Michael-type additions and aldol reactions.14−18
Despite large steps that have been made in techniques to
construct small smart libraries, typically only a small fraction of
the mutants within a library display the desired improved
characteristics.19−21 Especially improving the catalytic rate is
challenging, as it is diﬃcult to predict how mutations inﬂuence
the catalytic machinery of the enzyme. As a consequence, the
screening of mutants is still considered to be the bottleneck in
enzyme engineering.20
Ultrahigh-throughput screening techniques, such as ﬂuo-
rescence-activated cell sorting (FACS)22 and ﬂuorescence-
activated droplet sorting (FADS),23,24 have enabled the
screening of very large mutant libraries to enrich these libraries
for active mutants. The resulting enriched libraries are small
enough that they can be screened using lower throughput
screening techniques such as 96-well assays, or high-perform-
ance liquid chromatography/gas chromatography (HPLC/
GC)-based assays to identify individual mutants with the
desired characteristic. The eﬀectiveness of this approach was
elegantly demonstrated by the FADS-based directed evolution
of retroaldolase RA95.5-8, improving the catalytic eﬃciency
>20-fold.11,25 However, these techniques require specialized
equipment and nontrivial reaction setup.
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Here, we present a simple prescreening technique based on
the iminium-activated colorimetric turn-on probe 1b to
prescreen large 4-OT mutant libraries for improved activity
toward the iminium-mediated Michael-type addition of 2 to 1a
(Figure 1). The principle behind the prescreening technique is
based on the iminium species that is selectively formed
between 1b and Pro-1 of 4-OT (Figure 1). This structure
resembles a merocyanine dye and results in a new relatively
bathochromic absorption peak that can easily be observed by
the naked eye. This staining is not, or to a much lesser extent,
observed in many inactive mutants, which allows for those
mutants to be excluded from subsequent screenings. We
Figure 1. 4-OT catalyzed Michael-type addition, Brooker’s merocyanine, and the reaction between Pro-1 of 4-OT and cinnamaldehydes. (a) 4-OT
catalyzed Michael-type addition of 2 to 1a. Product R-3 is a precursor for Phenibut. (b) Resonance forms of Brooker’s merocyanine. (c) Turn-on
probes 1b and 1c reacting with Pro-1 of 4-OT, forming a zwitterionic resonating species. (d) Compounds 1a, 1d, and 1e reacting with Pro-1 of 4-
OT, forming a species without zwitterionic resonance.
Figure 2. Absorption spectra of 1b−1e in the presence and absence of 4-OT M45T/F50A. (a) Absorption spectrum of 1b with and without 4-OT
M45T/F50A. (b) Absorption spectrum of 1c with and without 4-OT M45T/F50A. (c) Absorption spectrum of 1d with and without 4-OT M45T/
F50A. (d) Absorption spectra of 1e with and without 4-OT M45T/F50A. Conditions: 2.5% dimethyl sulfoxide (DMSO), 20 mM sodium
phosphate (pH 7.3), 1 mM 1b−1e, 50 μM 4-OT M45T/F50A, 1 cm quartz cuvettes.
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applied this technique in a solid-phase preselection assay that
was termed as activated iminium colony staining (AICS).
AICS prescreening reduced screening eﬀorts up to 20-fold and
allowed for the screening of large mutant libraries. After two
rounds of directed evolution, we could improve the Michaelase
activity of 4-OT for the addition of 2 to 1a up to 39-fold. We
show that the principle behind AICS can be extended to other
iminium-based biocatalysts like the class I aldolase 2-deoxy-D-
ribose 5-phosphate aldolase (DERA), which potentially paves
the way for the engineering of novel biocatalysts for iminium-
mediated C−C bond-forming reactions.
■ RESULTS
Identiﬁcation of a Selective Turn-On Probe for 4-OT.
Recently, it was shown that Pro-1 of 4-OT can react with 1a to
form complex 5a, a catalytic intermediate in the Michael-type
addition of 2 to 1a yielding 3.18 Analogously, we hypothesized
that 1b and 1c could react with Pro-1 of 4-OT to form 5b and
5c, respectively, structures that bear chemical resemblance to
Brooker’s merocyanine (4) (Figure 1). Compound 4 is a
member of the diverse class of merocyanine dyes, which are
characterized by an electron-donating N-atom connected via a
streptopolymethine chain to an electron-withdrawing carbonyl
group.26,27 As a consequence, merocyanine dyes possess a
neutral and zwitterionic resonance form and have a relatively
high λmax. As compound 1b nor 1c nor free 4-OT bear this
characteristic chemical scaﬀold, incubation of 1b and 1c with
4-OT is expected to induce the formation of complexes 5b and
5c, respectively, each having a new relatively bathochromic
absorption peak.
To test this hypothesis, 1b and 1c were chemically
synthesized (Figure S1). As a control, we synthesized
compounds 1d and 1e that, like substrate 1a, should not be
able to form merocyanine dye-type structures upon con-
densation with Pro-1 of 4-OT because they lack an o-OH or p-
OH group (Figure 1d). For testing, we used 4-OT M45T/
F50A, a well-studied 4-OT mutant that was constructed for the
synthesis of 1a via the aldol condensation of acetaldehyde with
benzaldehyde.15 Gratifyingly, upon incubation of 1b or 1c with
4-OT M45T/F50A, the color of the solution changed within a
few seconds (Figure 2). Spectroscopic analysis revealed the
appearance of a novel absorption peak at 516 nm for 1b and
478 nm for 1c, whereas incubation of 4-OT M45T/F50A with
1d and 1e did not reveal any new absorption peaks (Figure 2).
Especially, the bright red species that was formed upon
incubation of 1b with 4-OT M45T/F50A could clearly be seen
by the naked eye, which made 1b a powerful turn-on probe for
4-OT. A single-site binding relationship between 1b and 4-OT
M45T/F50A was observed, with an estimated KD of 0.119 ±
0.0055 mM, which indicates that binding of 1b to 4-OT is site-
speciﬁc (Figure S2).
To gain further evidence for the formation of complex 5b, 4-
OT M45T/F50A was incubated with 1b for 15 min, followed
by the addition of NaCNBH3 to reduce any iminium species
and covalently trap the interaction of the probe and the
protein. Subsequent analysis by electrospray ionization mass
spectrometry (ESI-MS) showed a mass consistent with that of
4-OT M45T/F50A modiﬁed with a single molecule of 1b
(Figure S3). Control reactions with 4-OT M45T/F50A
incubated with only 1b or only NaCNBH3 did not show any
modiﬁcation. The labeled 4-OT was digested with the
endoproteinase Glu-C and the resulting peptides were
analyzed by ESI-MS, revealing the labeling of 1b on the
peptide fragment Pro-1 to Glu-9 (Figure S4). As Pro-1 is the
only likely candidate on this peptide to form an iminium
species with 1b, Pro-1 was reckoned as the site of labeling.
Interestingly, incubation of 1b with the enzyme 2-deoxy-D-
ribose 5-phosphate aldolase (DERA), a well-studied class I
aldolase,4,28 also resulted in an increase in absorbance at 516
nm (Figure S5), implicating broader applicability of probe 1b.
Mutants with Improved Michaelase Activity Show
Strong Staining with 1b. Having developed a selective turn-
on probe for 4-OT, we were interested in applying this system
to aid our directed evolution eﬀorts. Therefore, the eﬀect of
mutations of 4-OT on staining with 1b was investigated. Cells
producing a deﬁned set of 53 single mutants, covering nearly
all single mutants at positions 6, 45, and 50 were grown in a
deep 96-well plate. These positions were selected because
mutations at these positions have shown to inﬂuence the
activity of 4-OT for several promiscuous reactions.14−16,18
Incubation of cells producing the 53 single mutants with 1b
demonstrated that single mutations can signiﬁcantly aﬀect the
staining with 1b (Figure S6). Most notably, single mutants 4-
OT F50A, F50I, and F50V showed strong staining upon
incubation with 1b. Interestingly, these three mutants were
previously found in a screen for mutants with enhanced activity
for the Michael-type addition of 2 to 1a, forming 3.18 These
results prompted us to investigate if 1b could be used as a
prescreening tool to enrich libraries for mutants with activity
towards the Michael-type addition of 2 to 1a yielding 3, a
precursor for phenibut, an important γ-aminobutyric acid
(GABA) analogue.
Activated Iminium Colony Staining-Based Directed
Evolution of 4-OT. To improve the Michaelase activity of 4-
Figure 3. Activity for the Michael-type addition of 2 to 1a catalyzed by diﬀerent 4-OT mutants. (a) Progress curve of the Michael-type addition of
2 to 1a catalyzed by diﬀerent 4-OT mutants. (b) Initial rate of the Michael-type addition of 2 to 1a catalyzed by diﬀerent 4-OT mutants. The data
are presented as fold increase compared to the initial rate of starting mutant 4-OT F50A. Assay conditions: 5% ethanol, 20 mM N-(2-
hydroxyethyl)piperazine-N′-ethanesulfonic acid (HEPES) (pH 6.5), 1 mM 1a, 100 mM 2, 50 mM sodium formate.
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OT for the addition of 2 to 1a, we started by constructing a
triple-site NNK library. We randomized the active site residues
Gln-4, Leu-8, and Met-45 in the context of 4-OT F50A, the
reported best mutant for this reaction,18 yielding library Q4X/
L8X/M45X/F50A. The addition of 0.2% lactose to agar plates
induced the expression of 4-OT in freshly transformed cells,
without any eﬀect on the transformation eﬃciency. A solution
of 0.75% agarose containing 1b was poured on the agar plate
and was allowed to solidify. Within 1 min, ∼5% of the colonies
stained bright red and could be distinguished from other
colonies by the naked eye.
A total of 1472 stained colonies were picked and screened
for an improved activity for the addition of 2 to 1a. Several
mutants with improved activity were identiﬁed. Almost all
mutants harbored the M45I mutation, without any obvious
additive eﬀect of mutations at positions 4 and 8. Hence, double
mutant 4-OT M45I/F50A was constructed, which showed a
20-fold improvement in activity compared to 4-OT F50A,
using optimized reaction conditions (Figure 3).
In the second round of directed evolution, two libraries, 2−
20_IA and 21−40_IA, were constructed containing a single
random mutation from positions 2−20 and 21−40, respec-
tively in the context of 4-OT M45I/F50A. No mutations were
introduced in the C-terminal part of 4-OT (positions 41−62)
as this region is highly important for stabilization of the
hexameric structure.29 The library was transformed into
Escherichia coli cells, and colonies were stained using the
AICS assay (Figure 4). Comparing the activity of 92 stained
colonies with 92 unstained colonies of library 21−40_IA
demonstrated the high sensitivity of AICS prescreening, as
32% of the stained mutants showed activity comparable or
higher than the parental mutant 4-OT M45I/F50A, whereas all
of the unstained mutants showed no activity or less than 50%
of the activity of the parental mutant 4-OT M45I/F50A
(Figure 5).
From each library, 368 stained colonies were picked and
screened for an improved activity for the addition of 2 to 1a.
Although library 2−20_IA yielded many active mutants,
unfortunately, none were signiﬁcantly more active than the
parental mutant 4-OT M45I/F50A. Gratifyingly, library 21−
40_IA yielded two improved triple mutants: 4-OT S37E/
M45I/F50A and 4-OT A33E/M45I/F50A with 29- and 39-
fold improved activity compared to 4-OT F50A (Figure 3).
The synthetic usefulness of the newly engineered mutants 4-
OT S37E/M45I/F50A and 4-OT A33E/M45I/F50A was
demonstrated in semipreparative scale Michael-type addition
reactions using substrates 1a and 2. Target product R-3 could
be obtained in good to excellent isolated yield (up to 95%) and
with excellent enantiopurity (up to >99% enantiomeric excess,
ee) (Table S1 and Figures S7−S11). Given that only a small
number of colonies were assayed, these results demonstrate the
power of using the AICS prescreening tool for the rapid
engineering of iminium biocatalysis.
■ DISCUSSION
The use and development of novel, higher throughput
screening systems have drawn considerable attention.30 As
the screening of large mutant libraries is often limiting enzyme
engineering eﬀorts, systems that reduce screening eﬀorts or
allow for higher throughput of screening have signiﬁcantly
attributed to the success of enzyme engineering studies.25,31,32
The design of novel smart (pre)screening techniques is
therefore expected to have a strong impact. We wanted to
contribute to this ﬁeld by designing a smart iminium-based
Figure 4. Agar plates 10 s (left) and 4 min (right) after performing the AICS assay. Transformants of library 21−40_IA were stained with the AICS
assay as described in the Experimental Section.
Figure 5. Activity for the Michael-type addition of 2 to 1a catalyzed
by CFEs of 92 stained and 92 unstained colonies. Colonies from cells
that were freshly transformed with library 21−40_IA were stained
using the AICS procedure. In total, 92 stained colonies and 92
unstained colonies were picked, grown overnight, and the CFE was
assayed for the Michaelase activity using substrates 2 and 1a. The
Michaelase activity was measured in a plate reader by following the
depletion of 1a at 290 nm. Assay conditions: 5% ethanol, 30% CFE,
0.5 mM 1a, 100 mM 2, 50 mM sodium formate. Analysis of CFEs of
unstained colonies by sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) showed that eight out of 16 show
signiﬁcant 4-OT expression, indicating that the AICS procedure can
eﬃciently be used to eliminate colonies not producing enzyme or
producing enzyme with low-level activity.
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turn-on probe that could be used to remove a considerable part
of 4-OT mutants with no or low activity from large mutant
libraries.
Although there are a few reports on turn-on probes that
make use of an activated lysine in the acceptor protein,33−35
these studies focused on noncatalytic proteins. Instead, we
aimed to design the ﬁrst iminium-activated turn-on probe for
an enzyme, exploiting the characteristic nucleophilic N-
terminal proline of 4-OT. In the past, we showed that 1a
binds speciﬁcally to Pro-1 of 4-OT, forming 5a (Figure 1d).18
Hence, we designed turn-on probes 1b and 1c, which are close
mimics of substrate 1a. Incubation of 1b and 1c with 4-OT
M45T/F50A resulted in the formation of a novel relatively
bathochromic absorption peak characteristic of merocyanine
dyes. Especially, incubation of turn-on probe 1b with 4-OT
M45T/F50A induced a remarkable spectroscopic shift that
could easily be observed by the naked eye. Labeling studies
further supported our hypothesis that Pro-1 of 4-OT reacts
with 1b to form merocyanine dye 5b. Note that substrate 1a
and analogues 1d and 1e, which were prepared as controls,
cannot form merocyanine dye-type structures upon condensa-
tion with Pro-1 of 4-OT because they lack an o-OH or p-OH
group (Figure 1d).
Merocyanine dye 5b is very similar to 5a, a key catalytic
intermediate for the Michael-type addition of 2 to 1a.
Therefore, we investigated if there is a correlation between
4-OT single mutants that upon incubation with probe 1b show
strong staining and 4-OT single mutants with improved
Michaelase activity. Indeed, we found that, from a subset of 4-
OT single mutants, speciﬁcally mutants with enhanced
Michaelase activity showed strong staining upon incubation
with 1b. This inspired us to use turn-on probe 1b as a
prescreening tool in the engineering of improved artiﬁcial
Michaelases. We developed the AICS technique, a colorimetric
solid-phase prescreening procedure based on selective staining
of colonies producing an active 4-OT mutant with 1b, and
used it to enrich large libraries for active 4-OT mutants. The
developed AICS prescreening technique proved to be highly
eﬀective, reducing the screening eﬀort for a single round of
directed evolution up to 20-fold. In addition, the sensitivity of
AICS prescreening proved to be very high, as from a subset of
92 unstained colonies all showed less than 50% activity
compared to the parental mutant.
After two rounds of directed evolution, two triple mutants,
4-OT S37E/M45I/F50A and 4-OT A33E/M45I/F50A, were
identiﬁed with a 29- and 39-fold improvement in activity
compared to starting mutant 4-OT F50A. Semipreparative
scale reactions of the Michael-type addition of 2 to 1a
catalyzed by 4-OT S37E/M45I/F50A and 4-OT A33E/M45I/
F50A resulted in the isolation of target product R-3 with
excellent yield (up to 95%) and enantiopurity (ee up to
>99%).
The developed AICS prescreening technique provides a
novel application of turn-on probes, adding to the usage of
turn-on probes as tools for noninvasive tissue imaging or
colorimetric pH sensors.36−38 Contrary to many reported
colorimetric assays (e.g., refs 39−42), AICS does not rely on a
(coupled) chemical reaction producing a chromogenic
product, but instead solely relies on a conjugate formed
between the probe and the enzyme. As such, AICS is very
quick and nicely complements available reported colorimetric
assays.
It would be interesting to investigate the application of AICS
to a broader range of iminium biocatalysts, as preliminary
results indicate that turn-on probe 1b was also activated by the
lysine-dependent aldolase DERA. The further development of
turn-on probes as tools for enzyme engineering potentially
opens up new possibilities for the eﬃcient engineering of novel
classes of iminium-based biocatalysts.
■ EXPERIMENTAL SECTION
Spectrophotometric Analysis of 1b−1e Incubated
with Puriﬁed 4-OT. A stock solution of 40 mM 1b−1e was
prepared in 100% DMSO. A total of 25 μL was added to a
solution of 20 mM sodium phosphate buﬀer (pH 7.3) with and
without 50 μM 4-OT M45T/F50A; the ﬁnal volume was 1
mL. The mixture was transferred to a 1 cm quartz cuvette and
a spectrum from 350 to 800 nm was recorded. To analyze the
binding behavior of 1b to 4-OT M45T/F50A, a binding curve
was constructed. 1b (4−0 mM, 2-fold dilution series in 20 mM
sodium phosphate pH 7.3, 5% DMSO) was incubated with 4-
OT M45T/F50A (50 μM) for 15 min (300 μL ﬁnal volume).
The mixtures were transferred to 1 mm quartz cuvettes and the
absorbance at 516 nm was recorded and plotted against the
concentration of 1b. The experiment was performed in
triplicate. SigmaPlot was used to ﬁt the data against the one-
site saturation model and to calculate the apparent KD value
(Figure S2).
Covalent Labeling of 1b to 4-OT. To gain further
evidence for the formation of 5b, 4 mM 1b was incubated with
150 μM 4-OT M45T/F50A in 10 mM sodium phosphate (pH
7.3), 5% DMSO at room temperature; the total volume was
500 μL. After 15 min, 167 μL of 100 mM NaCNBH3 was
added in H2O to reduce any iminium species. The reaction was
incubated at room temperature for 30 min. The buﬀer was
exchanged to 10 mM ammonium formate in H2O using a
prepacked PD-10 sephadex G-25 gelﬁltration column. A
sample of the collected enzyme was analyzed by ESI-MS
(Figure S3). From the remaining fraction, 36 μL was digested
with GluC (New England BioLabs, 4 μL from a 100 ng/μL
stock solution) in a total volume of 80 μL for 24 h at 37 °C
using the supplied buﬀer. A sample from the digested mixture
was analyzed by ESI-MS. As controls, reaction without 1b and
reaction without the addition of NaCNBH3 (no reduction)
were included. In both cases, no modiﬁed 4-OT could be
detected by ESI-MS (Figures S3 and S4).
Staining of 4-OT Single Mutants with 1b. From a
reported set of 4-OT single mutants,16 BL21 DE3 glycerol
stocks of all single mutants with a mutation at positions 6, 45,
or 50 were used to inoculate 1 mL of lysogeny broth (LB)
medium supplemented with ampicillin (100 μg/mL) and
IPTG (100 μM) and grown overnight at 37 °C in 96-deep well
plates (Greiner Bio-one, 96-well Masterblock), covered with
sterile gas-permeable seals (Greiner Bio-one, BREATHseal).
The cells were harvested by centrifugation and the supernatant
was removed. The cell pellets were resuspended in 200 μL of
20 mM sodium phosphate buﬀer (pH 7.3) and 50 μL was
transferred to a round bottom 96-well plate (96-well U-
bottom, Greiner Bio-One). To this, 2.5 μL of 40 mM 1b in
100% DMSO was added. The cells were allowed to settle on
the bottom of the 96-well plate.
Cloning and Mutagenesis. Triple-site library 4-OT
Q4X/L8X/M45X/F50A was constructed by polymerase
chain reaction (PCR) with degenerate primers. The ﬁrst part
of the 4-OT gene was ampliﬁed using the following primers:
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GAGCGCGAGATGGCC-3′. The mutated codons Gln-4
and Leu-8 are indicated in bold. Met-45 was randomized
using primers 5′-GTGATTATCACGGAGNNKGC-
C A A G G G C C A C - 3 ′ a n d 5 ′ -
GTGGCCCTTGGCMNNCTCCGTGATAATCAC-3′ by
means of QuikChange technology. DNA of 4-OT F50A was
used as a template. The mutated codon Met-45 is indicated in
bold. The second part of 4-OT was ampliﬁed from the
QuikChange product using the following primers: 5′-
GGCCATCTCGCGCTCCCTG-3′ and 5′-GCTAGGGG-
G A T C C T C A G C G T C T G A C C T T G C T G G C -
CAGTTCGCCGCC-3′, using the QuikChange product as
template. The ampliﬁed parts of the 4-OT gene were
combined by overlap extension PCR and further ampliﬁed
using primers 5′-TTGAAGGAGATATACATATGCCT-3′
and 5′-GCTAGGGGGATCCTCAGCG-3′. An empty
pET20b backbone was generated by ampliﬁcation of a
pET20b plasmid using the following primers: 5′-TGGGCAA-
TAGGCATATGTATATCTCCTTCTTAAAGTTAAAC-3′
and 5′-AAGGTCAGACGCTGAGGATCCGAATTC-
GAGCTCCG-3′. The assembled 4-OT gene and the empty
pET20b backbone were puriﬁed and digested with restriction
enzymes NdeI, BamHI, and DpnI. The empty pET20b
backbone was dephosphorylated using alkaline phosphatase.
The digested DNA products were puriﬁed and ligated by T4
DNA ligase. The ligation mixture was puriﬁed and used to
electroporate electrocompetent E. coli DH5α cells. After 1 h of
outgrowth with SOC medium, a small sample of the
transformed DH5α cells was spread on an agar plate to
determine the transformation eﬃciency. The remainder of the
transformation mixture was added to 5 mL LB medium,
supplemented with ampicillin (100 μg/mL), and grown
overnight. The overnight culture was harvested and the
plasmids were isolated and used to transform BL21 DE3 cells.
For the construction of library 2−20_IA, a previously
reported set of nearly all single mutants was used.16 From a
glycerol stock, each DH10B culture that carried a plasmid
harboring a 4-OT gene with a mutation at positions 2−20 was
separately grown overnight in 300 μL of LB medium
supplemented with ampicillin (100 μg/mL). From all
individual cultures, 100 μL of each was mixed together.
From a sample of this mixed culture, plasmid DNA was
isolated to obtain a library of 4-OT genes with a random single
mutation at positions 2−20. The second part of the 4-OT gene
was ampliﬁed using the following primers: 5′-GATTAT-
C A C G G A G A T TG C C A A G G G C C A CG C CGG -
CATCGGCGGCG-3′ and 5′-GCTAGGGGGATCCT-
CAGCG-3′. The mutated residues Ile-45 and Ala-50 are
indicated in bold. Using the library of 4-OT genes with a
random single mutation at positions 2−20 as a template, the
ﬁrst part of the 4-OT gene was ampliﬁed using the following
primers: 5′-TTGAAGGAGATATACATATGCCT-3′ and 5′-
C G C CGCCG A TGCCGGCGTGGCCC T TGG -
CAATCTCCGTGATAATC-3′. Using overlap extension PCR,
a full-length 4-OT gene was obtained containing a random
mutation at positions 2−20, combined with the M45I and
F50A mutation. The full-length 4-OT gene was digested,
ligated, and cloned into the pET20b plasmid according to the
procedure described for the construction of the Q4X/L8X/
M45X/F50A library to obtain library 2−20_IA. The same
procedure was followed for the construction of library 21−
40_IA, using the single mutants with a mutation at positions
21−40.
Expression and Puriﬁcation of Enzymes. All 4-OT
mutants were expressed and puriﬁed according to a reported
procedure.7 DERA with C-terminal His-tag was expressed and
puriﬁed from E. coli using the pET20b(+) expression system. A
colony of freshly transformed BL21 DE3 cells was used to
inoculate 5 mL of LB medium supplemented with ampicillin
(100 μg/mL) and grown for 8 h at 37 °C. This starter culture
was used to innoculate 100 mL of LB medium supplemented
with ampicillin (100 μg/mL) and lactose (0.2% w/v). The
cells were incubated at 30 °C overnight at 200 rpm in a shaker
incubator. Cells were harvested by centrifugation, resuspended
in 30 mL of 20 mM potassium phosphate buﬀer (pH 7.0), and
lysed by sonication. The lysate was cleared by centrifugation
and transferred to a clean tube. Ni-sepharose (0.5 mL) was
added to the lysate and incubated at 4 °C under slow rotation
for 30 min. The lysate with Ni-sepharose was loaded on a
column, washed with 8 mL of 20 mM potassium phosphate
buﬀer (pH 7.0), followed by 8 mL of 20 mM potassium
phosphate buﬀer (pH 7.0) containing 30 mM imidazole. Final
elution was performed with 2.5 mL of 20 mM potassium
phosphate buﬀer (pH 7.0) containing 250 mM imidazole
(>95% purity as assessed by SDS-PAGE). The buﬀer was
exchanged to 20 mM potassium phosphate buﬀer (pH 7.0)
using a prepacked PD-10 sephadex G-25 gelﬁltration column.
The concentration of the puriﬁed enzyme was determined by
the Waddell method.43 DERA K167L was puriﬁed according
to the same protocol. After puriﬁcation, the puriﬁed DERA and
DERA K167L were immediately used in subsequent experi-
ments.
Activated Iminium Colony Staining (AICS). BL21 DE3
cells were transformed with library DNA and plated on LB agar
plates supplemented with ampicillin (100 μg/mL) and lactose
(0.2% w/v). Colonies were grown for ∼16 h at 37 °C, after
which the agar plate was stored at room temperature. A
solution of 1.5% agarose in H2O was prepared by heating in a
microwave and the solution was kept at 60 °C. A second
solution of 1 mM 1b dissolved in 20 mM sodium phosphate
(pH 7.3) was ﬁlter sterilized and stored at room temperature.
Seven milliliters of the 1.5% agarose solution were mixed with
7 mL of the solution containing 1 mM 1b in 20 mM sodium
phosphate and immediately after mixing poured on the agar
plate. Typically, staining of the ﬁrst colonies was observed after
10 s. The plate was incubated at room temperature for 5 min
to complete the staining and the agarose was allowed to
solidify. The staining is stable for at least several hours. For
screening of libraries 2−20_IA and 21−40_IA, the concen-
tration of 1b in the second solution was reduced to 0.5 mM to
increase the stringency of selection.
Library Screening. Colonies that showed clear staining
after the AICS assay were picked with sterile toothpicks and
were used to inoculate 1 mL of LB medium supplemented with
ampicillin (100 μg/mL) and lactose (0.2% w/v) in 96-deep
well plates (Greiner Bio-one, 96-well Masterblock). Two wells
in the 96-deep well plate were used to inoculate the parental
mutant (4-OT F50A or 4-OT M45I/F50A). The plates were
sealed with sterile gas-permeable seals (Greiner Bio-one,
BREATHseal) and incubated at 37 °C, with overnight shaking
at 250 rpm. Eighty microliters of the culture were mixed with
20 μL of a sterile solution of 80% glycerol in H2O and stored at
−80 °C for later reference. The remainder of the culture was
centrifuged. The supernatant was discarded and the pellets
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were resuspended with 200 μL of BugBuster (Novagen)
supplemented with 15 U/mL benzonase (Novagen). After 20
min of incubation at room temperature, the lysates were
cleared by centrifugation after which the CFE was obtained.
For the screening of libraries 2−20_IA and 21−40_IA, prior to
centrifugation, the lysed cells were diluted with 200 μL of
sterile H2O. For the screening of library Q4X/L8X/M45X/
F50A, the ﬁnal reaction mixture for monitoring the addition of
2 to 1a consisted of 40% CFE, 25 mM 2, 250 μM 1a, 5%
ethanol in 20 mM HEPES, pH 6.5; the ﬁnal volume was 100
μL. For the screening of libraries 2-20_IA and 21−40_IA, the
ﬁnal reaction mixture for monitoring the addition of 2 to 1a
consisted of 30% CFE, 100 mM 2, 1 mM 1a, 50 mM sodium
formate, 5% ethanol in 20 mM HEPES pH 6.5; the ﬁnal
volume was 100 μL. Sodium formate was added to the reaction
mixture, as this was found to positively aﬀect the catalytic rate
of 4-OT M45I/F50A. The reaction was performed in a 96-well
plate (Greiner Bio-one, UV-star F-bottom microplate) and
reaction progress was followed in a plate reader by following
the depletion in absorbance at 290 nm. For the screening of
libraries 2−20_IA and 21−40_IA, the initial absorbance was
too high for the plate reader, so the time point at which the
absorbance went below the absorbance threshold of the plate
reader was used as a reference point for activity. For the
comparison of the activity of 92 stained mutants with 92
unstained mutants, the same procedure as described for library
21−40_IA was followed. However, the reaction mixtures
consisted of 0.5 mM 1a instead of 1 mM 1a.
Progress Curves of the Enzymatic Reactions. For
monitoring the progress of the enzymatic addition of 2 to 1a
the following reaction setup was used. To a solution of 1a in
ethanol, 2 in 20 mM HEPES (pH 6.5) and puriﬁed 4-OT
F50A, 4-OT M45I/F50A, 4-OT S37E/M45I/F50A or 4-OT
A33E/M45I/F50A were added. The ﬁnal reaction mixture
consisted of the following: 5% ethanol, 20 mM HEPES (pH
6.5), 1 mM 1a, 100 mM 2, 50 mM sodium formate, 20 μM 4-
OT. The reaction mixtures were transferred to 1 mm quartz
cuvettes and the absorption at 290 nm was recorded every 20
s.
Semipreparative Scale Reactions. Semipreparative scale
experiments were performed using 4-OT S37E/M45I/F50A
and 4-OT A33E/M45I/F50A as biocatalysts. The reaction
mixtures consisted of the following: 5 mL ethanol (5% v/v), 20
mg 1a, 25 mM 2, 50 mM sodium formate, 20 mM HEPES (pH
6.5), 7.5 μM enzyme; the ﬁnal volume was 100 mL. At timely
intervals, a sample was withdrawn from the reaction mixture
and the reaction progress was monitored by following the
depletion in absorbance at 290 nm. After 10.5 h for 4-OT
S37E/M45I/F50A and 7.5 h for 4-OT A33E/M45I/F50A, the
reaction was ﬁnished and the reaction mixture was extracted
3× with 20 mL ethyl acetate. The combined organic layers
were washed with brine and dried over anhydrous Na2SO4. For
the reaction catalyzed by S37E/M45I/F50A, the organic layer
was concentrated in vacuo, yielding 3 (27.8 mg, 95% isolated
yield). For the 4-OT A33E/M45I/F50A catalyzed reaction, the
organic layer was concentrated in vacuo and the product was
puriﬁed by silica gel column chromatography (hexane/ethyl
acetate 4:1) to obtain 3 (16.0 mg, 55% yield).
Condensation of 1b with DERA and 4-OT. The
condensation of 1b with DERA and 4-OT was monitored in
time by following the absorbance at 516 nm. For the
condensation with DERA and DERA K167L, a 2× stock
solution was prepared consisting of the following: 20 mM
potassium phosphate (pH 7.0), 10% DMSO, and 8 mM 1b.
The stock solution (500 μL) was mixed in a 1 cm quartz
cuvette with 500 μL of 200 μM DERA or DERA K167L (5.54
mg/mL) in 20 mM potassium phosphate (pH 7.0).
Immediately after mixing, the absorbance at 516 nm was
measured every 0.5 s for 190 s. For 4-OT, a 2× stock solution
was prepared consisting of the following: 20 mM HEPES (pH
6.5), 10% ethanol, and 0.6 mM 1b. The stock solution (500
μL) was mixed in a 1 cm quartz cuvette with 500 μL of 100
μM 4-OT in 20 mM HEPES (pH 6.5). Immediately after
mixing, the absorbance at 516 nm was measured every 0.1 s for
190 s.
Derivatization of 3 for Enantiomeric Excess Determi-
nation. The aldehyde functionality of 3 was derivatized to a
cyclic acetal according to a literature procedure.44,45 The
enantiopurity of derivatized 3 was analyzed by reverse-phase
HPLC using a column with a chiral stationary phase (chiralpak
AD-RH, 150 mm × 4.6 mm, Daicel); detection at 220 nm,
retention time for R-3 was 8.8 min and for S-3, it was 12.2 min.
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